Salas Solana, ES
Jordi Salas Solana, Granollers (barcelona) ES
Patent application number | Description | Published |
---|---|---|
20140323475 | EP1 RECEPTOR LIGANDS - The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them. | 10-30-2014 |
Jordi Salas Solana, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20150376129 | SUBSTITUTED BENZAMIDES WITH ACTIVITY TOWARDS EP4 RECEPTORS - The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP4 receptor as well as to pharmaceutical compositions comprising them. | 12-31-2015 |
Jorge Salas Solana, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090306038 | 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity - 2-Aminopyrimidine derivatives of formula (I) that are useful as modulators of the H | 12-10-2009 |
20100113420 | PYRROLOPYRIMIDINE DERIVATIVES AS JAK3 INHIBITORS - Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors. | 05-06-2010 |
20100204187 | Purine Derivatives - Purine derivatives of Formula (I), wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK3 kinase inhibitors. | 08-12-2010 |
20110160185 | PYRROLOPYRIMIDINE DERIVATIVES AS JAK3 INHIBITORS - Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors. | 06-30-2011 |
Jorge Salas Solana, Granollers ES
Patent application number | Description | Published |
---|---|---|
20120245140 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS - N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors. | 09-27-2012 |
20130131038 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS - N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors. | 05-23-2013 |
20130289015 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS - N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors. | 10-31-2013 |